Salud y Fitness
Diabetes Self-Management

Diabetes Self-Management

May/June 2020

Diabetes Self-Management offers up-to-date, practical “how-to” information on nutrition, exercise, new drugs, medical advances, self-help, and the many other topics people need to know about to stay healthy.

País:
United States
Idioma:
English
Editor:
Madavor Media, LLC
Leer Más
COMPRAR NÚMERO
7,49 €(IVA inc.)
SUSCRIBIRSE
14,02 €(IVA inc.)
6 Números

en este número

1 min.
••• editor’s note •••

Dear Readers, Summer is getting underway, which means longer days and more time spent outdoors. You’ll find that our recipes (page 40) have been handpicked with this time of year in mind. From our selection of plant-based burgers to dishes that will inspire you to fire up the grill, you’ll be dining al fresco in style! While all the time spent outside soaking up the rays can lead to a natural boost in mood, managing diabetes is hard work no matter the season, and you may need a little extra help maintaining your mental wellness. Whether you’re trying just a little too hard to achieve “perfect” blood sugar control (page 28), are looking for an empathetic peer to share in your diabetes dilemmas and victories (page 24), or are having difficulty overcoming…

2 min.
trijardy xr

Even though some people with type 2 diabetes take more than one medication, they may still find it difficult to get their blood sugar under control. They could take even more pills, but that can be challenging. So it’s worth knowing that the U.S. Food and Drug Administration (FDA) has just approved a diabetes medication that combines three diabetes drugs in a single tablet. The medication is called Trijardy XR, and it’s marketed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly. Trijardy XR is a combination of three diabetes medications: empagliflozin (brand name Jardiance), linagliptin (Tradjenta) and an extended-release version of metformin. Both empagliflozin and linagliptin are tablets that patients with type 2 diabetes take once a day to lower blood sugar. Empagliflozin is also used to reduce the risk of cardiovascular…

2 min.
new smart insulin patch could be a game changer

We’ve been hearing a lot about “smart” devices these days—smart locks, smart cars, smart speakers, even smart refrigerators. Now a team of researchers and bioengineers at three schools—UCLA, Massachusetts Institute of Technology (MIT) and UNC School of Medicine—report they have developed a smart insulin patch. The new device, they say, has shown the ability first to monitor blood sugar and then manage insulin levels in people with diabetes. According to Zhen Gu, PhD, of UCLA, “Our main goal is to enhance health and improve the quality of life for people who have diabetes. This smart patch takes away the need to constantly check one’s blood sugar and then inject insulin if and when it’s needed.” The patch is about the size of a quarter and is equipped with tiny microneedles. The…

1 min.
cvs: option with no out-of-pocket costs

As the high out-of-pocket costs of insulin and other diabetes drugs have received widespread media coverage in recent months, many different stakeholders—from insulin manufacturers to state legislatures to health insurers—have taken action to reduce costs for certain groups of people. Now, CVS Health has announced a program that may eliminate out-of-pocket costs for diabetes drugs for many people with private and employer-sponsored health insurance plans. In a press release, the company announced that its pharmacy benefits manager division—CVS Caremark—will create an option called RxZERO for employers and private health insurers under which diabetes drugs, including insulin, carry no out-of-pocket costs for plan members. Employers and insurers can choose this option at no extra cost to themselves or plan members, according to CVS—meaning that premiums and deductibles will not change. According to the…

3 min.
mental health

With summer approaching and an increase in sun, you may be feeling a mood boost. Did you know that diabetes also affects mental health? Take this quiz to see how much you know about the link. 1. People with diabetes are at an increased risk of developing mental health issues. ∘ True ∘ False 2. Which of the following best explains why fluctuations in glucose can result in mood swings in those with type 1 diabetes? ∘ A. High glucose leads to hunger and shakiness. ∘ B. Changes in glucose affect the pancreas. ∘ C. Changes in glucose affect the brain. ∘ D. Low glucose leads to high energy. 3. What can you do to help lower stress and anxiety associated with managing diabetes? ∘ A. Contact an understanding friend or family member. ∘ B. Do relaxation exercises, such as yoga…

2 min.
fda not recommending metformin recall

Recently, we wrote that the U.S. Food and Drug Administration (FDA) was testing batches of the type 2 diabetes drug metformin for a potential contaminant. This contaminant, N-nitrosodimethylamine—more commonly known as NDMA—may contribute to cancer, and the FDA has established an upper limit for how much of it any drug sold in the United States can contain. NDMA is a potential byproduct of certain drug manufacturing processes. Now, the FDA has announced in a press release that the results are in—and there’s very little for anyone who takes metformin to worry about. Out of all the different batches of metformin from different manufacturers that the FDA tested, levels of NDMA ranged from undetectable to low, coming in well below the agency’s established limit. In a more detailed announcement of its laboratory analysis,…